Dublin, Dec. 06, 2017 -- The "Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) (Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis, Funding Scenario, Trend Analysis, and Competitive Landscape)" report has been added to Research and Markets' offering.
The global next generation market was estimated at $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024
The global next generation sequencing market is expected to grow with a double digit compound annual growth rate between the years 2017 and 2024. With substantial increase in the demand for genome mapping programs and diagnostics tests based on sequencing, the NGS market is expected to witness impressive growth and promises to be a lucrative field for investment. Kits & consumables sub segment dominated the product segment of global next generation sequencing market in 2016. However, the software sub segment is expected to witness the highest CAGR in the forecast period from 2017 to 2024.
NGS technologies have evolved in terms of high resolution and accuracy, sequencing speed, throughput, and cost-effectiveness in genomic analysis to accelerate biological and biomedical research. The NGS technologies are implemented in several applications namely pharmaceuticals, diagnostics, forensics, agriculture and animal research. Additionally, the double digit growth rate of the NGS market was largely fuelled by the rise in the demand for precision medicine, liquid biopsy tests, and Non-Invasive Prenatal Testing (NIPT), among others.
The purpose of the study is to gain a holistic view of the next generation sequencing market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the technologies allied with the next generation sequencing market. The global next generation sequencing market is segmented in to four different parts namely by product, by technology, by application and by geography. The global market value was estimated using these four different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation and to gain holistic view of the market.
Additionally, the reversible terminator sequencing technology currently dominates the global NGS market. The emerging technologies such as Nanopore technology is estimated to witness the highest CAGR in the forecast period.
Key Topics Covered:
Executive Summary
1 Report Scope & Methodology
2 Market Overview
2.1 Introduction
2.2 History of Next Generation Sequencing
3 Market Dynamics
3.1 Promoting and Inhibiting Factors of the Next Generation Sequencing Market Growth
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Challenges
4 Competitive Landscape
4.1 Key Developments and Strategies
4.2 Market Share Analysis by Company
4.3 Market Share by Companies, by Instruments
4.4 Market Share by Companies, by Kits & Consumables
4.5 Industry Attractiveness
5 Funding Scenario
5.1 Key Players of the Market are Investing Substantial Amounts in Bioinformatics Start-ups
6 Industry Insights
6.1 Legal Requirements and Regulations
6.2 List of Regulatory Bodies
6.3 Role of Service Providers in Next Generation Sequencing Market
7 Global Next Generation Sequencing Market by Product
7.1 Introduction
7.2 Instruments
7.2.1 Integrated Workflow Instruments
7.2.2 Sequencing Instruments
7.2.3 Library Preparation Instruments
7.3 Kits & Consumables
7.3.1 Library Preparation Kits
7.3.2 Target Enrichment Kits
7.3.3 Sequencing Kits
7.3.4 Multiuse Kits
7.4 Software
8 Global Next Generation Sequencing Market by Technology
8.1 Introduction
8.2 Ion Torrent Semiconductor Sequencing
8.3 Reversible Terminator Sequencing
8.4 Single Molecule Real Time Sequencing
8.5 Nanopore Sequencing Technologies
8.6 Other Technologies
9 Global Next Generation Sequencing Market by Application
9.1 Introduction
9.2 Pharmaceuticals
9.3 Diagnostics
9.4 Agricultural and Animal Research
9.5 Forensics
9.6 Others
10 Global Next Generation Sequencing Market by Geography
11 Company Profiles
- 10x Genomics
- BGI
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- GATC Biotech AG.
- GENEWIZ
- GenapSys, Inc.
- Illumina, Inc.
- New England Biolabs, Inc.
- NuGEN Technologies Inc.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California, Inc.
- Partek, Inc.
- PerkinElmer, Inc.
- QIAGEN
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/7qtj6x/global_next
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



